Lineage Cell Therapeutics Inc (LCTX)
1.14
0.00 (0.00%)
USD |
NYAM |
Apr 23, 15:55
Lineage Cell Therapeutics Price to Book Value: 3.389 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.389 |
| April 19, 2024 | 3.419 |
| April 18, 2024 | 3.567 |
| April 17, 2024 | 3.835 |
| April 16, 2024 | 3.419 |
| April 15, 2024 | 3.716 |
| April 12, 2024 | 3.865 |
| April 11, 2024 | 4.192 |
| April 10, 2024 | 4.013 |
| April 09, 2024 | 4.162 |
| April 08, 2024 | 4.370 |
| April 05, 2024 | 4.162 |
| April 04, 2024 | 4.281 |
| April 03, 2024 | 4.043 |
| April 02, 2024 | 4.162 |
| April 01, 2024 | 4.340 |
| March 28, 2024 | 4.400 |
| March 27, 2024 | 4.162 |
| March 26, 2024 | 3.894 |
| March 25, 2024 | 3.805 |
| March 22, 2024 | 3.776 |
| March 21, 2024 | 4.043 |
| March 20, 2024 | 3.627 |
| March 19, 2024 | 3.597 |
| March 18, 2024 | 3.478 |
| Date | Value |
|---|---|
| March 15, 2024 | 3.835 |
| March 14, 2024 | 3.448 |
| March 13, 2024 | 3.597 |
| March 12, 2024 | 3.686 |
| March 11, 2024 | 3.835 |
| March 08, 2024 | 3.865 |
| March 07, 2024 | 3.359 |
| March 06, 2024 | 3.359 |
| March 05, 2024 | 3.211 |
| March 04, 2024 | 3.389 |
| March 01, 2024 | 3.300 |
| February 29, 2024 | 3.091 |
| February 28, 2024 | 3.091 |
| February 27, 2024 | 3.239 |
| February 26, 2024 | 3.091 |
| February 23, 2024 | 3.061 |
| February 22, 2024 | 3.18 |
| February 21, 2024 | 3.150 |
| February 20, 2024 | 3.239 |
| February 16, 2024 | 3.358 |
| February 15, 2024 | 3.358 |
| February 14, 2024 | 3.061 |
| February 13, 2024 | 3.031 |
| February 12, 2024 | 3.210 |
| February 09, 2024 | 3.210 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6904
Minimum
Dec 23 2019
4.934
Maximum
Feb 17 2021
2.567
Average
2.856
Median
Price to Book Value Benchmarks
| Acumen Pharmaceuticals Inc | 0.7078 |
| Sarepta Therapeutics Inc | 12.82 |
| CEL-SCI Corp | 6.187 |
| AIM ImmunoTech Inc | 2.183 |
| IGC Pharma Inc | 3.105 |
Price to Book Value Related Metrics
| PS Ratio | 22.00 |
| Price | 1.14 |
| Earnings Yield | -10.53% |
| Market Cap | 214.93M |